Many studies [6,27,35,61,65–67] have used CD34+KDR+ or CD34+KDR+CD133+ cells to study COPD, coming to different conclusions based on the characterization of the EPCs, and few have examined COPD subphenotypes. This evidence concerns the gene KDR and chronic obstructive pulmonary disease.